Daniel R Morales

Biography

Dr Morales is a General Practitioner conducting epidemiology and pharmacoepidemiology research. His interests include investigating the intended and adverse effects of drugs, medicines utilisation, risk communication and regulatory science. He also has direct experience of medicines regulation through his role as a national expert to the European Medicines Agency.

Research Interest

Guthrie B. Davis S, Donnan P, Payne K, Morales DR (CA), Thompson A. Accounting for multimorbidity, competing risk and direct treatment disutility in risk prediction tools and model-based cost-effectiveness analysis for the primary prevention of cardiovascular disease and osteoporotic fracture. NIHR Health Services and Delivery Research Programme. In progress.  Morales DR (PI), Donnan PT, Lipworth B. Respiratory effect of angiotensin-converting enzyme inhibitors in people with asthma: a pharmacoepidemiological analysis using linked UK primary care data. Tenovus Scotland Major Research Grant. June 2016 to Sep 2017. Morales DR (PI), Zhang J, Flynn R. Application of support vector machine learning to predict the risk of death from chronic obstructive pulmonary disease using electronic primary care medical records. Chief Scientist Office. July 2015 to July 2016. Mead G, Hankey G, Lewis S, Graham C, Anderson C, Hackett M, House AO, Sullivan F, Morales DR (CA), Macleod M, Murray V, Lundström E, Dennis M. A Multicentre randomised trial to establish the effect (s) of routine administration of Fluoxetine in patients with a recent stroke. NIHR Health Technology Assessment Programme. Oct 2014 to March 2019. Morales DR (PI), Donnan P, Jackson C, Guthrie B. Measuring the risk of ß-blocker and NSAID prescribing in asthma. Chief Scientist Office, Scottish Government Health Department Clinical Academic Fellowship. Sep 2011 to Sep 2014. Dreischulte T, Morales DR (Co-PI), Guthrie B, Donnan PT. Risk of renal events following triple whammy exposure. NHS Tayside Anonymous Trust Grant. Aug 2012 to Aug 2014. Marwick C, Morales DR (Co-PI), Donnan PT. Validation of a clinical prediction rule for community acquired Clostridium difficile infection after antibiotic prescription in older patients. NHS Tayside Anonymous Trust Grant. Sep 2013 to Dec 2014.